# A Study in Healthy People to See How Zongertinib is Taken up Into the Blood When Given as Tablets Made by Two Different Manufacturers

> **NCT06360081** · PHASE1 · COMPLETED · sponsor: **Boehringer Ingelheim** · enrollment: 56 (actual)

## Conditions studied

- Healthy

## Interventions

- **DRUG:** Zongertinib manufacturer 1
- **DRUG:** Zongertinib manufacturer 2

## Key facts

- **NCT ID:** NCT06360081
- **Lead sponsor:** Boehringer Ingelheim
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2024-04-30
- **Primary completion:** 2024-06-30
- **Final completion:** 2024-07-15
- **Target enrollment:** 56 (ACTUAL)
- **Last updated:** 2025-09-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06360081

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06360081, "A Study in Healthy People to See How Zongertinib is Taken up Into the Blood When Given as Tablets Made by Two Different Manufacturers". Retrieved via AI Analytics 2026-07-17 from https://api.ai-analytics.org/clinical/NCT06360081. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*